Amphastar Pharmaceuticals Stock Price - AMPH

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 20.64 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Amphastar Pharmaceuticals Inc AMPH NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.18 0.88% 20.64 20.885 20.41 20.44 20.46 16:00:44
Bid Price Ask Price Spread Spread % News
19.00 20.76 1.76 8.48% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,858 136,248 $ 20.72 $ 2,822,439 247,912 17.71 - 25.43
Last Trade Time Type Quantity Stock Price Currency
16:08:11 61 $ 20.64 USD

Amphastar Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 974.75M 47.23M $ -5.74M -0.12 18.00 46.29M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Amphastar Pharmaceuticals News

Loading Messages....

Latest AMPH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMPH Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week19.8720.88519.4719.9799146k0.773.88%
1 Month21.7521.7619.0220.2136195k-1.11-5.10%
3 Months19.0322.8518.6620.9765217k1.618.46%
6 Months20.8923.318.4720.8057187k-0.25-1.20%
1 Year18.2725.4317.7121.0710200k2.3712.97%
3 Years18.0125.4312.0518.3750232k2.6314.60%
5 Years10.3225.439.75917.0875238k10.32100.00%

Amphastar Pharmaceuticals Description

Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable and inhalation products. The business activities are operated through two reportable segments namely finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, naloxone, lidocaine, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API. Its products are used in hospitals or urgent care clinical settings. Geographically the business presence of the firm is seen in the United States and France of which the US accounts for the majority of revenue.

Your Recent History
Amphastar ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.